TNF and autoimmune disease: Since autoimmune diseases are mediated by proinflammatory cytokines (especially TNF-α and IL-1β) [9, 23], which are responsible for dysfunction of the respective target cells effective therapeutic regimes require treatment with a TNF-α antibody [24].